Angiotensin converting enzyme in the human basal forebrain and midbrain visualized by in vitro autoradiography
- 8 January 1990
- journal article
- research article
- Published by Wiley in Journal of Comparative Neurology
- Vol. 291 (2) , 179-194
- https://doi.org/10.1002/cne.902910203
Abstract
Angiotensin converting enzyme converts angiotensin I to angiotensin II, a peptide that plays an important role in the central regulation of blood pressure and fluid and electrolyte homeostasis. However, the distribution of this enzyme in the human brain has not been well described. In this study, angiotensin converting enzyme was mapped in the human basal forebrain and midbrain by using quantitative in vitro autoradiography employing a derivative of a potent converting enzyme inhibitor, 125I‐351A, as radioligand. This radioligand binds specifically and with high affinty to angiotensin converting enzyme and also exhibited these properties in binding to slide‐mounted sections of human basal ganglia.In the basal ganglia, high levels of binding of 125I‐351A are found in the caudate nucleus, putamen, nucleus accumbens, both divisions of the globus pallidus, and substantia nigra pars reticulata. High densities of labelling also occur in the ventral pallidum. In the hypothalamus, a moderate level occurs in the paraventricular and supraoptic nuclei, and a diffuse, low level of binding is found throughout the periventricular region.The organum vasculosum of the lamina terminalis, one of the circumventricular organs, displays the highest concentration of binding. The choroid plexus contains only moderate density of labelling in contrast to other mammalian species previously studied. Major fibre tracts are devoid of activity except for the posterior limb of the internal capsule, which contains fascicles of intense activity.In the midbrain, a moderate density of binding is detected in the periaqueductal gray. The dorsal, central linear, and, more caudally, the centralis superior medialis raphe nuclei also contain moderate densities of labelling.Angiotensin converting enzyme is heterogeneously distributed in the caudate nucleus and putamen, with distinct patches of high concentrations surrounded by a matrix of diffuse, lower levels. In the caudate nucleus, these patches of high binding corresponded to striosomes since they register with acetylcholinesterase‐poor zones.The high concentration of angiotensin converting enzyme found in the basal ganglia suggests that the enzyme may be involved in processing neuropeptides that occur in high concentrations in these structures. Possible substance P and enkephalins, which are also concentrated in striosomes.Keywords
This publication has 54 references indexed in Scilit:
- Effects of nigral dopaminergic lesions and striatal excitotoxin lesions on brain converting enzymeNeurochemistry International, 1987
- Acetylcholinesterase staining of the human amygdalaNeuroscience Letters, 1985
- Organization of Angiotensin II Immunoreactive Cells and Fibers in the Rat Central Nervous SystemNeuroendocrinology, 1985
- Inhibition of Angiotensin I-Converting Enzyme with S 9490Journal of Cardiovascular Pharmacology, 1984
- A new feature of angiotensin-converting enzyme in the brain: Hydrolysis of substance PBiochemical and Biophysical Research Communications, 1983
- Enkephalinase: Selective peptide inhibitorsLife Sciences, 1981
- Conversion of [met5] -enkephalin-Arg6-Phe7 to [met5]-enkephalin by dipeptidyl carboxypeptidaseNeuropharmacology, 1981
- Angiotensin converting enzyme in the Parkinsonian brainAnnals of Neurology, 1978
- Angiotensin-Converting Enzyme: Vascular Endothelial LocalizationScience, 1976
- Studies of the vertebrate telencephalon. II. The nuclear pattern of the anterior olfactory nucleus, tuberculum olfactorium and the amygdaloid complex in adult manJournal of Comparative Neurology, 1941